Literature DB >> 18218696

Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells.

Damian G Romero1, Maria W Plonczynski, Cristian A Carvajal, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez.   

Abstract

MicroRNAs (miRNAs) are endogenous small noncoding RNAs that decrease the expression levels of specific genes by translational repression, sequestration, and degradation of their mRNAs. Angiotensin II is an important modulator of adrenal zona glomerulosa cell physiology, including steroidogenesis and proliferation among many other physiological processes. Because each miRNA may regulate the expression levels of multiple genes, thereby resembling the transcription regulatory networks triggered by transcription factors, we hypothesize that specific miRNAs may be involved in angiotensin II-mediated adrenocortical cell physiology. The human adrenocortical cell line H295R is the only adrenal cell line available with a steroid secretion pattern and regulation similar to freshly isolated adrenocortical cells. We screened for miRNAs regulated by angiotensin II in H295R cells and found that miRNA-21 expression levels were specifically modulated by angiotensin II. Angiotensin II time dependently increased miRNA-21 expression reaching a 4.4-fold induction after 24 h. Angiotensin II-mediated miRNA-21 expression resulted in biologically active miRNA-21, determined using a fusion mRNA reporter system carrying miRNA-21 target sequences in its 3' untranslated region. Up-regulation of miRNA-21 intracellular levels increased aldosterone secretion but not cortisol. Elevation of miRNA-21 levels also increased cell proliferation in H295R cells. In summary, miRNA-21 is an endogenously expressed miRNA in human adrenal cells. miRNA-21 expression is up-regulated by angiotensin II, and its overexpression caused an increase in aldosterone secretion and cell proliferation. Alterations in miRNA-21 expression levels or function may be involved in dysregulation of angiotensin II signaling and abnormal aldosterone secretion by adrenal glands in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218696      PMCID: PMC2329274          DOI: 10.1210/en.2007-1686

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

4.  Interleukin-8 synthesis, regulation, and steroidogenic role in H295R human adrenocortical cells.

Authors:  Damian G Romero; Gaston R Vergara; Zheng Zhu; Gina S Covington; Maria W Plonczynski; Licy L Yanes; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2005-11-03       Impact factor: 4.736

5.  Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion.

Authors:  I M Bird; N A Hanley; R A Word; J M Mathis; J L McCarthy; J I Mason; W E Rainey
Journal:  Endocrinology       Date:  1993-10       Impact factor: 4.736

6.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Authors:  Yunhui Cheng; Ruirui Ji; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

9.  Requirement of bic/microRNA-155 for normal immune function.

Authors:  Antony Rodriguez; Elena Vigorito; Simon Clare; Madhuri V Warren; Philippe Couttet; Dalya R Soond; Stijn van Dongen; Russell J Grocock; Partha P Das; Eric A Miska; David Vetrie; Klaus Okkenhaug; Anton J Enright; Gordon Dougan; Martin Turner; Allan Bradley
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

10.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.

Authors:  Angie M Cheng; Mike W Byrom; Jeffrey Shelton; Lance P Ford
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

View more
  20 in total

1.  Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas.

Authors:  Yang Jong Lee; Jin Mo Cho; Ju Hyung Moon; Cheol Ryong Ku; Jean Kim; Sun Ho Kim; Eun Jig Lee
Journal:  Endocrine       Date:  2017-08-14       Impact factor: 3.633

Review 2.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

3.  Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex.

Authors:  Kenneth T Krill; Katherine Gurdziel; Joanne H Heaton; Derek P Simon; Gary D Hammer
Journal:  Mol Endocrinol       Date:  2013-03-21

4.  Channels and pumps in aldosterone-producing adenomas.

Authors:  Celso E Gomez-Sanchez
Journal:  J Clin Endocrinol Metab       Date:  2014-04       Impact factor: 5.958

5.  Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.

Authors:  Alejandra Tapia-Castillo; Cristian A Carvajal; Jorge A Pérez; Carlos E Fardella
Journal:  Endocrine       Date:  2022-06-08       Impact factor: 3.925

Review 6.  The emerging role of microRNAs in cardiac remodeling and heart failure.

Authors:  Vijay Divakaran; Douglas L Mann
Journal:  Circ Res       Date:  2008-11-07       Impact factor: 17.367

7.  MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells.

Authors:  Zhigang Hu; Wen-Jun Shen; Fredric B Kraemer; Salman Azhar
Journal:  Mol Cell Biol       Date:  2012-10-08       Impact factor: 4.272

Review 8.  The role of miRNAs in regulating adrenal and gonadal steroidogenesis.

Authors:  Salman Azhar; Dachuan Dong; Wen-Jun Shen; Zhigang Hu; Fredric B Kraemer
Journal:  J Mol Endocrinol       Date:  2020-01       Impact factor: 5.098

Review 9.  Epigenetic modification: a regulatory mechanism in essential hypertension.

Authors:  Mohammed Arif; Sakthivel Sadayappan; Richard C Becker; Lisa J Martin; Elaine M Urbina
Journal:  Hypertens Res       Date:  2019-03-13       Impact factor: 3.872

10.  The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.

Authors:  Deniz M Özata; Stefano Caramuta; David Velázquez-Fernández; Pinar Akçakaya; Hong Xie; Anders Höög; Jan Zedenius; Martin Bäckdahl; Catharina Larsson; Weng-Onn Lui
Journal:  Endocr Relat Cancer       Date:  2011-10-27       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.